Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis
Mucorales are fungal pathogens that cause mucormycosis, a lethal angioinvasive disease. Previously, we demonstrated that , the most common cause of mucormycosis, invades endothelial cells by binding of its CotH proteins to the host receptor GRP78. Loss of CotH3 renders the fungus noninvasive and att...
Gespeichert in:
Veröffentlicht in: | Science advances 2019-06, Vol.5 (6), p.eaaw1327-eaaw1327 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | eaaw1327 |
---|---|
container_issue | 6 |
container_start_page | eaaw1327 |
container_title | Science advances |
container_volume | 5 |
creator | Gebremariam, Teclegiorgis Alkhazraji, Sondus Soliman, Sameh S M Gu, Yiyou Jeon, Heewon H Zhang, Lina French, Samuel W Stevens, David A Edwards, Jr, John E Filler, Scott G Uppuluri, Priya Ibrahim, Ashraf S |
description | Mucorales are fungal pathogens that cause mucormycosis, a lethal angioinvasive disease. Previously, we demonstrated that
, the most common cause of mucormycosis, invades endothelial cells by binding of its CotH proteins to the host receptor GRP78. Loss of CotH3 renders the fungus noninvasive and attenuates
virulence in mice. Here, we demonstrate that polyclonal antibodies raised against peptides of CotH3 protected diabetic ketoacidotic (DKA) and neutropenic mice from mucormycosis compared to mice treated with control preimmune serum. Passive immunization with anti-CotH3 antibodies enhanced neutrophil inlfux and triggered Fc receptor-mediated enhanced opsonophagocytosis killing of
. Monoclonal antibodies raised against the CotH3 peptide also protected immunosuppressed mice from mucormycosis caused by
and other Mucorales and acted synergistically with antifungal drugs in protecting DKA mice from
infection. These data identify anti-CotH3 antibodies as a promising adjunctive immunotherapeutic option against a deadly disease that often poses a therapeutic challenge. |
doi_str_mv | 10.1126/sciadv.aaw1327 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6561750</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2242170315</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-92ac409d0359879098e0a208e7922a5e5551054e771f187b4e73585b3172d2bb3</originalsourceid><addsrcrecordid>eNpVUU1LwzAYDqK4MXf1KDl66cxH07QXYQy_YOBFzyFN0y3S9q1JW9m_t2NzzNP7wPPxPvAgdEvJglKWPATjdDEstP6hnMkLNGVcioiJOL08wxM0D-GLEELjJBE0u0YTThlJCKNT1C6bzkUr6F451iPMoXA24NZDZ02Ha2csLj3UuO4N-HpnILiA892osIMdDdBgKLFrBh32WDcF1v2m3lPNBkMboIF2qzdgdt3ee4OuSl0FOz_eGfp8fvpYvUbr95e31XIdGZ6RLsqYNjHJCsJFlsqMZKklmpHUyowxLawQghIRWylpSVOZj4iLVOScSlawPOcz9HjIbfu8toUZC3ldqda7WvudAu3Uf6ZxW7WBQSUioVKQMeD-GODhu7ehU7ULxlaVbiz0QTEWMyoJp2KULg5S4yEEb8vTG0rUfil1WEodlxoNd-flTvK_XfgvxmSTag</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2242170315</pqid></control><display><type>article</type><title>Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Gebremariam, Teclegiorgis ; Alkhazraji, Sondus ; Soliman, Sameh S M ; Gu, Yiyou ; Jeon, Heewon H ; Zhang, Lina ; French, Samuel W ; Stevens, David A ; Edwards, Jr, John E ; Filler, Scott G ; Uppuluri, Priya ; Ibrahim, Ashraf S</creator><creatorcontrib>Gebremariam, Teclegiorgis ; Alkhazraji, Sondus ; Soliman, Sameh S M ; Gu, Yiyou ; Jeon, Heewon H ; Zhang, Lina ; French, Samuel W ; Stevens, David A ; Edwards, Jr, John E ; Filler, Scott G ; Uppuluri, Priya ; Ibrahim, Ashraf S</creatorcontrib><description>Mucorales are fungal pathogens that cause mucormycosis, a lethal angioinvasive disease. Previously, we demonstrated that
, the most common cause of mucormycosis, invades endothelial cells by binding of its CotH proteins to the host receptor GRP78. Loss of CotH3 renders the fungus noninvasive and attenuates
virulence in mice. Here, we demonstrate that polyclonal antibodies raised against peptides of CotH3 protected diabetic ketoacidotic (DKA) and neutropenic mice from mucormycosis compared to mice treated with control preimmune serum. Passive immunization with anti-CotH3 antibodies enhanced neutrophil inlfux and triggered Fc receptor-mediated enhanced opsonophagocytosis killing of
. Monoclonal antibodies raised against the CotH3 peptide also protected immunosuppressed mice from mucormycosis caused by
and other Mucorales and acted synergistically with antifungal drugs in protecting DKA mice from
infection. These data identify anti-CotH3 antibodies as a promising adjunctive immunotherapeutic option against a deadly disease that often poses a therapeutic challenge.</description><identifier>ISSN: 2375-2548</identifier><identifier>EISSN: 2375-2548</identifier><identifier>DOI: 10.1126/sciadv.aaw1327</identifier><identifier>PMID: 31206021</identifier><language>eng</language><publisher>United States: American Association for the Advancement of Science</publisher><subject>Animals ; Antibodies, Fungal - biosynthesis ; Antibodies, Fungal - pharmacology ; Antibodies, Monoclonal - biosynthesis ; Antibodies, Monoclonal - pharmacology ; Antifungal Agents - pharmacology ; Combined Modality Therapy ; Diabetic Ketoacidosis - immunology ; Diabetic Ketoacidosis - microbiology ; Diabetic Ketoacidosis - mortality ; Diabetic Ketoacidosis - therapy ; Disease Models, Animal ; Fungal Proteins - genetics ; Fungal Proteins - immunology ; Gene Expression ; Health and Medicine ; Heat-Shock Proteins - genetics ; Heat-Shock Proteins - immunology ; Host-Pathogen Interactions - immunology ; Humans ; Immunization, Passive - methods ; Immunocompromised Host ; Male ; Mice ; Mice, Inbred ICR ; Mucormycosis - immunology ; Mucormycosis - microbiology ; Mucormycosis - mortality ; Mucormycosis - therapy ; Neutropenia - immunology ; Neutropenia - microbiology ; Neutropenia - mortality ; Neutropenia - therapy ; Neutrophils - drug effects ; Neutrophils - immunology ; Neutrophils - microbiology ; Phagocytosis - drug effects ; Receptors, Immunologic - genetics ; Receptors, Immunologic - immunology ; Rhizopus - drug effects ; Rhizopus - pathogenicity ; SciAdv r-articles ; Survival Analysis ; Virulence</subject><ispartof>Science advances, 2019-06, Vol.5 (6), p.eaaw1327-eaaw1327</ispartof><rights>Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). 2019 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-92ac409d0359879098e0a208e7922a5e5551054e771f187b4e73585b3172d2bb3</citedby><cites>FETCH-LOGICAL-c390t-92ac409d0359879098e0a208e7922a5e5551054e771f187b4e73585b3172d2bb3</cites><orcidid>0000-0001-7608-6021 ; 0000-0001-7278-3700 ; 0000-0003-3787-8530</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561750/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561750/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31206021$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gebremariam, Teclegiorgis</creatorcontrib><creatorcontrib>Alkhazraji, Sondus</creatorcontrib><creatorcontrib>Soliman, Sameh S M</creatorcontrib><creatorcontrib>Gu, Yiyou</creatorcontrib><creatorcontrib>Jeon, Heewon H</creatorcontrib><creatorcontrib>Zhang, Lina</creatorcontrib><creatorcontrib>French, Samuel W</creatorcontrib><creatorcontrib>Stevens, David A</creatorcontrib><creatorcontrib>Edwards, Jr, John E</creatorcontrib><creatorcontrib>Filler, Scott G</creatorcontrib><creatorcontrib>Uppuluri, Priya</creatorcontrib><creatorcontrib>Ibrahim, Ashraf S</creatorcontrib><title>Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis</title><title>Science advances</title><addtitle>Sci Adv</addtitle><description>Mucorales are fungal pathogens that cause mucormycosis, a lethal angioinvasive disease. Previously, we demonstrated that
, the most common cause of mucormycosis, invades endothelial cells by binding of its CotH proteins to the host receptor GRP78. Loss of CotH3 renders the fungus noninvasive and attenuates
virulence in mice. Here, we demonstrate that polyclonal antibodies raised against peptides of CotH3 protected diabetic ketoacidotic (DKA) and neutropenic mice from mucormycosis compared to mice treated with control preimmune serum. Passive immunization with anti-CotH3 antibodies enhanced neutrophil inlfux and triggered Fc receptor-mediated enhanced opsonophagocytosis killing of
. Monoclonal antibodies raised against the CotH3 peptide also protected immunosuppressed mice from mucormycosis caused by
and other Mucorales and acted synergistically with antifungal drugs in protecting DKA mice from
infection. These data identify anti-CotH3 antibodies as a promising adjunctive immunotherapeutic option against a deadly disease that often poses a therapeutic challenge.</description><subject>Animals</subject><subject>Antibodies, Fungal - biosynthesis</subject><subject>Antibodies, Fungal - pharmacology</subject><subject>Antibodies, Monoclonal - biosynthesis</subject><subject>Antibodies, Monoclonal - pharmacology</subject><subject>Antifungal Agents - pharmacology</subject><subject>Combined Modality Therapy</subject><subject>Diabetic Ketoacidosis - immunology</subject><subject>Diabetic Ketoacidosis - microbiology</subject><subject>Diabetic Ketoacidosis - mortality</subject><subject>Diabetic Ketoacidosis - therapy</subject><subject>Disease Models, Animal</subject><subject>Fungal Proteins - genetics</subject><subject>Fungal Proteins - immunology</subject><subject>Gene Expression</subject><subject>Health and Medicine</subject><subject>Heat-Shock Proteins - genetics</subject><subject>Heat-Shock Proteins - immunology</subject><subject>Host-Pathogen Interactions - immunology</subject><subject>Humans</subject><subject>Immunization, Passive - methods</subject><subject>Immunocompromised Host</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred ICR</subject><subject>Mucormycosis - immunology</subject><subject>Mucormycosis - microbiology</subject><subject>Mucormycosis - mortality</subject><subject>Mucormycosis - therapy</subject><subject>Neutropenia - immunology</subject><subject>Neutropenia - microbiology</subject><subject>Neutropenia - mortality</subject><subject>Neutropenia - therapy</subject><subject>Neutrophils - drug effects</subject><subject>Neutrophils - immunology</subject><subject>Neutrophils - microbiology</subject><subject>Phagocytosis - drug effects</subject><subject>Receptors, Immunologic - genetics</subject><subject>Receptors, Immunologic - immunology</subject><subject>Rhizopus - drug effects</subject><subject>Rhizopus - pathogenicity</subject><subject>SciAdv r-articles</subject><subject>Survival Analysis</subject><subject>Virulence</subject><issn>2375-2548</issn><issn>2375-2548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUU1LwzAYDqK4MXf1KDl66cxH07QXYQy_YOBFzyFN0y3S9q1JW9m_t2NzzNP7wPPxPvAgdEvJglKWPATjdDEstP6hnMkLNGVcioiJOL08wxM0D-GLEELjJBE0u0YTThlJCKNT1C6bzkUr6F451iPMoXA24NZDZ02Ha2csLj3UuO4N-HpnILiA892osIMdDdBgKLFrBh32WDcF1v2m3lPNBkMboIF2qzdgdt3ee4OuSl0FOz_eGfp8fvpYvUbr95e31XIdGZ6RLsqYNjHJCsJFlsqMZKklmpHUyowxLawQghIRWylpSVOZj4iLVOScSlawPOcz9HjIbfu8toUZC3ldqda7WvudAu3Uf6ZxW7WBQSUioVKQMeD-GODhu7ehU7ULxlaVbiz0QTEWMyoJp2KULg5S4yEEb8vTG0rUfil1WEodlxoNd-flTvK_XfgvxmSTag</recordid><startdate>20190601</startdate><enddate>20190601</enddate><creator>Gebremariam, Teclegiorgis</creator><creator>Alkhazraji, Sondus</creator><creator>Soliman, Sameh S M</creator><creator>Gu, Yiyou</creator><creator>Jeon, Heewon H</creator><creator>Zhang, Lina</creator><creator>French, Samuel W</creator><creator>Stevens, David A</creator><creator>Edwards, Jr, John E</creator><creator>Filler, Scott G</creator><creator>Uppuluri, Priya</creator><creator>Ibrahim, Ashraf S</creator><general>American Association for the Advancement of Science</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7608-6021</orcidid><orcidid>https://orcid.org/0000-0001-7278-3700</orcidid><orcidid>https://orcid.org/0000-0003-3787-8530</orcidid></search><sort><creationdate>20190601</creationdate><title>Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis</title><author>Gebremariam, Teclegiorgis ; Alkhazraji, Sondus ; Soliman, Sameh S M ; Gu, Yiyou ; Jeon, Heewon H ; Zhang, Lina ; French, Samuel W ; Stevens, David A ; Edwards, Jr, John E ; Filler, Scott G ; Uppuluri, Priya ; Ibrahim, Ashraf S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-92ac409d0359879098e0a208e7922a5e5551054e771f187b4e73585b3172d2bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Antibodies, Fungal - biosynthesis</topic><topic>Antibodies, Fungal - pharmacology</topic><topic>Antibodies, Monoclonal - biosynthesis</topic><topic>Antibodies, Monoclonal - pharmacology</topic><topic>Antifungal Agents - pharmacology</topic><topic>Combined Modality Therapy</topic><topic>Diabetic Ketoacidosis - immunology</topic><topic>Diabetic Ketoacidosis - microbiology</topic><topic>Diabetic Ketoacidosis - mortality</topic><topic>Diabetic Ketoacidosis - therapy</topic><topic>Disease Models, Animal</topic><topic>Fungal Proteins - genetics</topic><topic>Fungal Proteins - immunology</topic><topic>Gene Expression</topic><topic>Health and Medicine</topic><topic>Heat-Shock Proteins - genetics</topic><topic>Heat-Shock Proteins - immunology</topic><topic>Host-Pathogen Interactions - immunology</topic><topic>Humans</topic><topic>Immunization, Passive - methods</topic><topic>Immunocompromised Host</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred ICR</topic><topic>Mucormycosis - immunology</topic><topic>Mucormycosis - microbiology</topic><topic>Mucormycosis - mortality</topic><topic>Mucormycosis - therapy</topic><topic>Neutropenia - immunology</topic><topic>Neutropenia - microbiology</topic><topic>Neutropenia - mortality</topic><topic>Neutropenia - therapy</topic><topic>Neutrophils - drug effects</topic><topic>Neutrophils - immunology</topic><topic>Neutrophils - microbiology</topic><topic>Phagocytosis - drug effects</topic><topic>Receptors, Immunologic - genetics</topic><topic>Receptors, Immunologic - immunology</topic><topic>Rhizopus - drug effects</topic><topic>Rhizopus - pathogenicity</topic><topic>SciAdv r-articles</topic><topic>Survival Analysis</topic><topic>Virulence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gebremariam, Teclegiorgis</creatorcontrib><creatorcontrib>Alkhazraji, Sondus</creatorcontrib><creatorcontrib>Soliman, Sameh S M</creatorcontrib><creatorcontrib>Gu, Yiyou</creatorcontrib><creatorcontrib>Jeon, Heewon H</creatorcontrib><creatorcontrib>Zhang, Lina</creatorcontrib><creatorcontrib>French, Samuel W</creatorcontrib><creatorcontrib>Stevens, David A</creatorcontrib><creatorcontrib>Edwards, Jr, John E</creatorcontrib><creatorcontrib>Filler, Scott G</creatorcontrib><creatorcontrib>Uppuluri, Priya</creatorcontrib><creatorcontrib>Ibrahim, Ashraf S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Science advances</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gebremariam, Teclegiorgis</au><au>Alkhazraji, Sondus</au><au>Soliman, Sameh S M</au><au>Gu, Yiyou</au><au>Jeon, Heewon H</au><au>Zhang, Lina</au><au>French, Samuel W</au><au>Stevens, David A</au><au>Edwards, Jr, John E</au><au>Filler, Scott G</au><au>Uppuluri, Priya</au><au>Ibrahim, Ashraf S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis</atitle><jtitle>Science advances</jtitle><addtitle>Sci Adv</addtitle><date>2019-06-01</date><risdate>2019</risdate><volume>5</volume><issue>6</issue><spage>eaaw1327</spage><epage>eaaw1327</epage><pages>eaaw1327-eaaw1327</pages><issn>2375-2548</issn><eissn>2375-2548</eissn><abstract>Mucorales are fungal pathogens that cause mucormycosis, a lethal angioinvasive disease. Previously, we demonstrated that
, the most common cause of mucormycosis, invades endothelial cells by binding of its CotH proteins to the host receptor GRP78. Loss of CotH3 renders the fungus noninvasive and attenuates
virulence in mice. Here, we demonstrate that polyclonal antibodies raised against peptides of CotH3 protected diabetic ketoacidotic (DKA) and neutropenic mice from mucormycosis compared to mice treated with control preimmune serum. Passive immunization with anti-CotH3 antibodies enhanced neutrophil inlfux and triggered Fc receptor-mediated enhanced opsonophagocytosis killing of
. Monoclonal antibodies raised against the CotH3 peptide also protected immunosuppressed mice from mucormycosis caused by
and other Mucorales and acted synergistically with antifungal drugs in protecting DKA mice from
infection. These data identify anti-CotH3 antibodies as a promising adjunctive immunotherapeutic option against a deadly disease that often poses a therapeutic challenge.</abstract><cop>United States</cop><pub>American Association for the Advancement of Science</pub><pmid>31206021</pmid><doi>10.1126/sciadv.aaw1327</doi><orcidid>https://orcid.org/0000-0001-7608-6021</orcidid><orcidid>https://orcid.org/0000-0001-7278-3700</orcidid><orcidid>https://orcid.org/0000-0003-3787-8530</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2375-2548 |
ispartof | Science advances, 2019-06, Vol.5 (6), p.eaaw1327-eaaw1327 |
issn | 2375-2548 2375-2548 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6561750 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Animals Antibodies, Fungal - biosynthesis Antibodies, Fungal - pharmacology Antibodies, Monoclonal - biosynthesis Antibodies, Monoclonal - pharmacology Antifungal Agents - pharmacology Combined Modality Therapy Diabetic Ketoacidosis - immunology Diabetic Ketoacidosis - microbiology Diabetic Ketoacidosis - mortality Diabetic Ketoacidosis - therapy Disease Models, Animal Fungal Proteins - genetics Fungal Proteins - immunology Gene Expression Health and Medicine Heat-Shock Proteins - genetics Heat-Shock Proteins - immunology Host-Pathogen Interactions - immunology Humans Immunization, Passive - methods Immunocompromised Host Male Mice Mice, Inbred ICR Mucormycosis - immunology Mucormycosis - microbiology Mucormycosis - mortality Mucormycosis - therapy Neutropenia - immunology Neutropenia - microbiology Neutropenia - mortality Neutropenia - therapy Neutrophils - drug effects Neutrophils - immunology Neutrophils - microbiology Phagocytosis - drug effects Receptors, Immunologic - genetics Receptors, Immunologic - immunology Rhizopus - drug effects Rhizopus - pathogenicity SciAdv r-articles Survival Analysis Virulence |
title | Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T08%3A04%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-CotH3%20antibodies%20protect%20mice%20from%20mucormycosis%20by%20prevention%20of%20invasion%20and%20augmenting%20opsonophagocytosis&rft.jtitle=Science%20advances&rft.au=Gebremariam,%20Teclegiorgis&rft.date=2019-06-01&rft.volume=5&rft.issue=6&rft.spage=eaaw1327&rft.epage=eaaw1327&rft.pages=eaaw1327-eaaw1327&rft.issn=2375-2548&rft.eissn=2375-2548&rft_id=info:doi/10.1126/sciadv.aaw1327&rft_dat=%3Cproquest_pubme%3E2242170315%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2242170315&rft_id=info:pmid/31206021&rfr_iscdi=true |